Additionally, the C/T (-159) polymorphism in the CD14 gene (rs2569190) has been closely linked to an increased risk in the development of NAFLD, however, without however influencing the degree of hepatic steatosis or fibrosis (109). The gene discussed is CD14; the disease is metabolic dysfunction-associated steatotic liver disease.